Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARGATROBAN vs DALTEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ARGATROBAN vs DALTEPARIN: Safety Overview

Metric ARGATROBAN DALTEPARIN
Total FAERS Reports 683 3,570
Deaths Reported 147 789
Death Rate 21.5% 22.1%
Hospitalizations 281 1,443
Average Patient Age 57.9 yrs 67.7 yrs
% Female Patients 42.7% 39.7%
FDA Approval Date Dec 15, 2014 Apr 4, 2002
Manufacturer Mullan Pharmaceutical Inc. Pfizer Laboratories Div Pfizer Inc
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Discontinued Prescription